Welcome to our dedicated page for Petmed Express news (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express stock.
PetMed Express, Inc. (PetMeds) (NASDAQ: PETS) generates a steady flow of corporate, financial, and operational news that is relevant to investors, analysts, and pet healthcare observers. As a national online pet pharmacy and parent company of PetCareRx, PetMeds regularly issues press releases and SEC reports covering its business performance, governance, regulatory status, and strategic developments.
News about PetMed Express often includes updates on its financial reporting, such as the filing of its Annual Report on Form 10-K and preliminary revenue information for fiscal quarters. The company has reported on investigations by its Audit Committee into accounting and control matters, the resulting restatement of certain prior financial statements, and the identification of material weaknesses in internal control over financial reporting. Related news items also cover notices from Nasdaq regarding delayed SEC filings and the company’s plans to regain compliance with listing requirements.
Corporate governance and leadership changes are another frequent news theme. PetMed Express has announced the resignation of senior executives, the appointment of an interim Chief Executive Officer and an interim principal financial officer, and the addition of independent directors with audit and financial expertise to its board. These updates provide insight into how the company is addressing oversight, financial governance, and board composition.
Strategic and transactional news includes unsolicited, non-binding acquisition proposals from investment firms such as SilverCape Investments Limited and Cardone Ventures, each expressing interest in acquiring all outstanding shares of PetMed Express at a specified cash price per share, subject to customary conditions. The company has also highlighted partnerships and initiatives in the pet healthcare community, such as fundraising efforts with the myBalto Foundation to support emergency veterinary care. Together, these news items offer a detailed view of PetMed Express’s evolving business, governance, and strategic landscape.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
PetMed Express, Inc. (NASDAQ: PETS) has completed the acquisition of PetCareRx for approximately $36 million in cash. This strategic move expands PetMeds' market reach from pet medications to a wider healthcare category. With the addition of around 10,000 new food, diet, and wellness products, PetMeds aims to enhance its product offerings and service capabilities for its over two million active customers. The acquisition will allow PetMeds to leverage a more efficient distribution network while maintaining the independent operation of PetCareRx's e-commerce platform, ensuring continuity in customer experience.
PetMed Express, Inc. (NASDAQ: PETS) reported its financial results for Q3 FY 2023, with net sales of $58.9 million, marking a 3% decline year-over-year. The company recorded a net loss of $19,000, translating to $(0.00) per diluted share, down from a net income of $4.3 million or $0.21 per share in the same quarter last year. Adjusted EBITDA fell 64% to $2.7 million. However, new customers increased by 9% year-over-year, the first rise in 10 quarters. The Board declared a $0.30 quarterly dividend, payable on February 27, 2023. Management believes ongoing investments, including the acquisition of PetCareRx, will foster long-term growth.
PetMed Express (PETS) has announced a conference call scheduled for February 6, 2023, at 4:30 PM Eastern Time to discuss its third-quarter financial results for the period ending December 31, 2022. This call will be preceded by a press release detailing the financial results. Interested parties can join via a U.S. dial-in number or international line, and a replay will be available until February 20, 2023. PetMed Express, founded in 1996, provides prescription and non-prescription medications for pets through its 1-800-PetMeds service and website. Key risks and uncertainties, including the company's ability to fulfill its business objectives, are noted in their SEC filings.